Norgestimate/Ethinyl Estradiol Tablets

Pre-Solicitation Posted

This opportunity was awarded. See its 2 award notices in the notice history.

Solicitation number
SPE2D2-25-R-0003
Agency
Responses due
Not on record
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Norgestimate/Ethinyl Estradiol Tablets. The procurement will be for various formulations of the pharmaceutical product, including Norgestimate Ethinyl Estradiol Triphasic Low Dose Oral Tablets, Norgestimate Ethinyl Estradiol Triphasic Oral Tablets, and Ethinyl Estradiol 0.035MG/Norgestimate 0.25MG Tablets. This will be an unrestricted and fully competitive acquisition, using a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract will establish a national supply source to provide the items to Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers. Interested parties should monitor the DLA Bid Board System (DIBBS) and Sam.Gov for the solicitation, which is currently projected to be issued in November of 2024, though DLA reserves the right to issue it before or after that date.

This procurement will not use any set-aside designations. Details on annual usage estimates and potential award values or budget ranges were not provided in the pre-solicitation notice. No information was given on any potential incumbent contractors.

Notice text

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Norgestimate/Ethinyl Estradiol Tablets. Procurement details follow.

Norgestimate Ethinyl Estradiol Triphasic Low Dose Oral Tablets (0.18/0.215/0.25 MG - 35MCG), Norgestimate Ethinyl Estradiol Triphasic Oral Tablets (0.18/0.215/0.25 MG - 25MCG), and Ethinyl Estradiol 0.035MG/Norgestimate 0.25MG TAB,28 in 3x28 count packs totaling 84 tabs in boxes.  This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Kyle Lewicki at (215) 737-3696, (kyle.lewicki@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.   

Notice history

Notice Type Posted
Pharm Manuf/Distr Div - FSA Latest Award Notice
Norgestimate/Ethinyl Estradiol Tablets Award Notice
Norgestimate/Ethinyl Estradiol Tablets Latest solicitation Solicitation
This notice Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside

See more similar opportunities on GovTribe

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login